Discriminative stimulus properties of anxiolytic and sedative drugs: pharmacological specificity - PubMed

Review

Discriminative stimulus properties of anxiolytic and sedative drugs: pharmacological specificity

D J Sanger. Psychopharmacol Ser. 1988.

Abstract

In the first set of experiments rats were trained to discriminate a dose of 5 mg/kg chlordiazepoxide from saline. The chlordiazepoxide cue was antagonized by flumazepil (Ro 15-1788) and by CGS 8216, and generalized to a variety of anxiolytic and sedative drugs including the benzodiazepine receptor ligands zopiclone, suriclone, CL 218,872, CGS 9896, and ZK 91296. The novel imidazopyridine hypnotic, zolpidem, which also displaces benzodiazepines from their binding sites, failed to produce high levels of responding on the chlordiazepoxide-associated level except at a dose which greatly reduced rates of lever pressing. In further experiments rats were trained to discriminate a dose of 2 mg/kg zolpidem from saline. This dose produced reductions in response rates but an attempt to establish a lower dose of zolpidem as a discriminative stimulus was largely unsuccessful. Zolpidem-appropriate responding was produced by pentobarbital, chlordiazepoxide, triazolam, CL 218,872, clorazepate, lorazepam, quazepam, and zopiclone but only at doses which reduced response rates. The zolpidem cue was antagonized by flumazepil, CGS 9896, and ZK 91296. While the discriminative stimulus produced by chlordiazepoxide may be related to its anxiolytic action, the zolpidem stimulus is probably more closely associated with sedation. It was also tentatively concluded that the stimulus properties of chlordiazepoxide and zolpidem are produced by activity at different subtypes of benzodiazepine receptors.

Similar articles

• The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic.

  Sanger DJ, Zivkovic B. Sanger DJ, et al. Psychopharmacology (Berl). 1986;89(3):317-22. doi: 10.1007/BF00174367. Psychopharmacology (Berl). 1986. PMID: 2873608

• Discriminative stimulus properties of chlordiazepoxide and zolpidem. Agonist and antagonist effects of CGS 9896 and ZK 91296.

  Sanger DJ, Zivkovic B. Sanger DJ, et al. Neuropharmacology. 1987 May;26(5):499-505. doi: 10.1016/0028-3908(87)90034-7. Neuropharmacology. 1987. PMID: 3037419

• Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.

  Rowlett JK, Spealman RD, Lelas S. Rowlett JK, et al. J Pharmacol Exp Ther. 1999 Dec;291(3):1233-41. J Pharmacol Exp Ther. 1999. PMID: 10565847

• The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure.

  Sanger DJ, Perrault G, Morel E, Joly D, Zivkovic B. Sanger DJ, et al. Physiol Behav. 1987;41(3):235-40. doi: 10.1016/0031-9384(87)90359-3. Physiol Behav. 1987. PMID: 3324120 Review.

• Comparison of discriminative stimuli produced by full and partial benzodiazepine agonists: pharmacological specificity.

  Bennett DA. Bennett DA. Psychopharmacol Ser. 1988;4:85-94. doi: 10.1007/978-3-642-73223-2_7. Psychopharmacol Ser. 1988. PMID: 2899320 Review.

Cited by

• Nonhuman animal models of substance use disorders: Translational value and utility to basic science.

  Smith MA. Smith MA. Drug Alcohol Depend. 2020 Jan 1;206:107733. doi: 10.1016/j.drugalcdep.2019.107733. Epub 2019 Nov 21. Drug Alcohol Depend. 2020. PMID: 31790978 Free PMC article. Review.

• Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic.

  Sanger DJ, Zivkovic B. Sanger DJ, et al. Psychopharmacology (Berl). 1994 Jan;113(3-4):395-403. doi: 10.1007/BF02245215. Psychopharmacology (Berl). 1994. PMID: 7862851

• Discriminative stimulus effects of melatonin in the rat.

  Levesque TR, Locke KW. Levesque TR, et al. Psychopharmacology (Berl). 1994 Oct;116(2):167-72. doi: 10.1007/BF02245059. Psychopharmacology (Berl). 1994. PMID: 7862946

Publication types

MeSH terms

Substances

LinkOut - more resources

• Research Materials

  • NCI CPTC Antibody Characterization Program